Serine.

Pyridoxal 5-phosphate, the active form of vitamin B6, is the required cofactor for serine hydroxymethyltransferase, serine racemase and cystathionine beta-synthase. Without adequate B6 status, serine is converted onward into glycine, D-serine or cysteine more slowly.

Serine hydroxymethyltransferase converts serine to glycine reversibly, so the two share one metabolic pool and each spares demand on the other. Both also occupy the same co-agonist site on NMDA receptors in normal neurotransmission.

When serine becomes glycine, its third carbon is handed to tetrahydrofolate to form 5,10-methylene-THF, the entry point for folate-dependent methylation and nucleotide synthesis. Folate supply and serine supply set the throughput of the same cycle.

In the transsulfuration pathway serine condenses with homocysteine to form cystathionine, which is then cleaved to cysteine. Cysteine formation at that step depends on serine being available.

Serine racemase converts L-serine into D-serine, which occupies the co-agonist site of the NMDA receptor complex. The L form is the source of the D form.

Free serine is the head group attached to a phospholipid backbone through base exchange to form phosphatidylserine. Serine supply sits directly upstream of that membrane lipid.

Serine is the carbon skeleton that transsulfuration turns into cysteine, and cysteine is the limiting amino acid for glutathione synthesis. Serine availability therefore sits upstream of the glutathione pool.

NAC supplies cysteine directly, reducing the demand on serine and homocysteine to build it through cystathionine. Both routes converge on the same cysteine pool.

Serine donates a carbon to tetrahydrofolate, and B12-dependent methionine synthase uses that unit to re-methylate homocysteine. Serine is the main carbon entry point into the cycle B12 runs.

Serine hydroxymethyltransferase moves serine's carbon onto tetrahydrofolate, producing the methylene-THF that is reduced to methylfolate. The two are consecutive steps of one pathway.

MTHFR needs riboflavin-derived FAD to convert the methylene-THF built from serine into methylfolate. Riboflavin status governs how far serine's donated carbon travels.

Threonine catabolism yields glycine, which interconverts with serine through serine hydroxymethyltransferase. The two amino acids feed one shared pool.

Serine and glycine carry one-carbon units through folate while choline carries them through betaine, and the two routes cover for each other when one is short. Both are also phospholipid head groups.

Phosphatidylserine is formed when free serine displaces the head group of an existing phospholipid such as phosphatidylcholine. The two lipids sit either side of that base exchange.

PHGDH oxidises 3-phosphoglycerate to 3-phosphohydroxypyruvate using NAD+ as the electron acceptor, which is what commits glycolytic carbon to the serine pathway. Niacin and its relatives are the dietary precursors of that NAD+ pool. The relationship is one of cofactor supply, not of niacin increasing serine levels in any measured way.

Almost every enzyme that makes serine or consumes it runs on pyridoxal 5-phosphate: the transamination step that builds it, the transfer of its beta-carbon to folate, its condensation with homocysteine, and its condensation with palmitoyl-CoA. Without adequate PLP those reactions slow regardless of how much serine is present. P5P is the pre-converted coenzyme form, which is the reason it appears as a separate ingredient from pyridoxine.

Selenocysteine, the residue at the active site of glutathione peroxidases and thioredoxin reductases, is not charged onto tRNA directly. Seryl-tRNA is made first, phosphorylated, and then the selenium donated by selenophosphate replaces the oxygen to give selenocysteinyl-tRNA. Serine therefore supplies the carbon skeleton for every selenoprotein the body makes, which is textbook biochemistry rather than a supplement finding.

Serine palmitoyltransferase joins serine to palmitoyl-CoA to give 3-ketosphinganine, which is reduced and acylated onward to ceramide and then to complex sphingolipids. Serine contributes the nitrogen and two carbons of every sphingoid base. Supplemental ceramides and dietary serine reach the same structural class from opposite ends, one preformed and one as raw material.

Cystathionine beta-synthase joins serine to homocysteine to form cystathionine, the committed step that draws methionine-derived sulfur toward cysteine. In the other direction, the methylene group serine donates to tetrahydrofolate is what eventually remethylates homocysteine back to methionine. Serine therefore sits on both exits from the homocysteine pool, which makes the pairing genuinely bidirectional.

Cysteine formed through cystathionine, which serine builds with homocysteine, is oxidised by cysteine dioxygenase and decarboxylated to hypotaurine and then taurine. Adequate serine supply supports the whole downstream branch, which also includes glutathione. Supplemental taurine bypasses that route entirely, so the two are complementary rather than duplicative.

Serine hydroxymethyltransferase loads tetrahydrofolate with the methylene group that MTHFR reduces to 5-methyl-THF, the methyl donor for homocysteine remethylation. The methionine produced is adenylated to SAM-e, the cell's general methyl donor. Serine is the upstream carbon supply for that cycle; SAM-e is the finished currency.

Betaine-homocysteine methyltransferase remethylates homocysteine using betaine as the donor, a route that runs largely in liver and kidney and does not need folate. The serine and folate route is the other one, active in most tissues. Supplying both means the cell is not dependent on a single methyl source, which is why they appear together in methylation formulas.

Guanidinoacetate methyltransferase uses SAM-e to make creatine, and this single reaction accounts for a substantial share of whole-body methyl group turnover. Supplemental creatine reduces the endogenous synthesis demand and therefore the methyl draw. Serine sits upstream as one of the carbon sources that keeps the methyl pool filled, so the two interact through a shared budget rather than a shared enzyme.

The second step of de novo serine synthesis transfers an amino group from glutamate to 3-phosphohydroxypyruvate, giving phosphoserine and alpha-ketoglutarate. Glutamine is the main circulating reservoir that supplies that glutamate in most tissues. The pairing is a nitrogen-supply relationship in a single pathway.

Mammalian phosphatidylserine synthases swap the head group of phosphatidylcholine or phosphatidylethanolamine for free serine in a calcium-dependent base-exchange reaction. Lecithin supplies the phospholipid backbones for that exchange, serine supplies the head group. Neither on its own describes the finished molecule.

Serine and proline both appear at meaningful frequency in collagen and other structural proteins, and both are synthesised endogenously from intermediates of central carbon metabolism. Supplying them together supports normal protein synthesis without either being rate-limiting for the other. The rationale is compositional, and no trial has measured the pair.

The formiminoglutamate step of histidine breakdown transfers a formimino group to tetrahydrofolate, feeding the same folate-bound one-carbon pool that serine hydroxymethyltransferase supplies. Serine is quantitatively the dominant donor; histidine is a minor secondary one. They converge on one pool rather than acting on each other.

Collagen peptides deliver a glycine- and proline-rich amino acid profile in which serine also appears. Free serine added alongside broadens that profile rather than replacing any part of it. No study has measured the combination, and the row rests on amino acid composition alone.

Gut bacteria carrying tryptophan synthase join indole to serine to build tryptophan, a route humans do not possess. Whether luminal serine meaningfully changes microbial tryptophan or indole metabolism in people has not been established. The row describes microbial biochemistry and should not be read as a human conversion.